Yield Growth Corp. (CSE:BOSS) is pleased to announce that it will launch three hemp-based skin care products next week under the Urban Juve brand: Vitalize Daily Face Moisturizer, Balance Daily Face Moisturizer and Align Daily Face Moisturizer.

Manufacturing of these three products began this week at a GMP compliant manufacturer in accordance with the highest industry standards in Canada. The 3 batches have already finished production and are undergoing final microbial testing, which takes 5-7 days. The product will be filled after all the quality assurance work is finished so it is safe for consumer use and ready for sale.


All of these products are made with proprietary formulations containing hemp oil and are carefully crafted with natural ingredients and made without parabens, mineral oil, sulphates, artificial fragrances, dyes, formaldehyde forming agents and phthalates. The products are not tested on animals and can carry the label “cruelty free”. The product packaging for all three products is fully recyclable. The moisturizers are registered for sale with Health Canada and will soon be available for sale in Canada through the Urban Juve website and other retailers.

“I am extremely proud of our talented team for bringing these beautiful products to the retail market in under two years,” says Yield Growth CEO, Penny Green, “Once the development work is complete, the potential profit margins on these products are high. We also expect to make healthy returns on our future planned cannabis infused topicals.”

The suggested retail price for the Urban Juve moisturizers is $65 per unit, whereas the cost per unit for raw ingredients, packaging and manufacturing is under $8, yielding a potentially lucrative margin for the company. Profit margins for concentrates and infused products in the cannabis sector are estimated at around 32% – significantly higher than those typically realized by alcohol, soft drinks, and cigarettes, according to the 2016 Marijuana Business Factbook.

The steps required to bring these Urban Juve products to market included research and development, bench scaling the product formulations, manufacturing processes and sourcing of the highest grade raw materials. Urban Juve ensures all of the products go through stability testing, preservative challenges, package stability testing and microbial quality assurance. The entirety of the process, from packaging sourcing and design to production, is in compliance with Health Canada product and packaging regulations.

The moisturizers, like many of Urban Juve’s products, have been developed based on ancient Ayurvedic principles to offer a customized experience for different Ayurvedic body types which have been modernized by the Urban Juve brand as Vitalize (Vata), Balance (Pita) and Align (Kapha).

Vitalize Daily Face Moisturizer is created for deep hydration for normal to dry skin. Made with rich and warming spice essential oils, it encourages circulation for a natural glow. Balance Daily Face Moisturizer provides soothing hydration for sensitive skin. Its potent blend of juniper berry, rose water and jasmine counteracts the toxins and irritants that cause redness and flare-ups. Align Daily Face Moisturizer bestows purifying hydration for oily skin. Its herbal essential oils have antibacterial and acne fighting properties. All of the moisturizers are made with hemp oil and hydrate, reduce inflammation and nourish the skin.

About The Yield Growth Corp.

The Yield Growth Corp. is dedicated to the rapid, sustainable financial growth of cannabis assets. Its directors and officers have experience working at multi-billion dollar international companies including M.A.C Cosmetics, Aritzia, Skechers, Best Buy, Future Shop, Pepsi and Coca-Cola.

Yield Growth owns 100% of Urban Juve Provisions Inc., which has synthesized ancient Ayurvedic knowledge and modern techniques to create a catalogue of over 50 exceptional personal care and wellness products. Urban Juve has registered with Health Canada 26 products containing cannabis sativa hemp oil. The company has also filed 11 provisional patent applications in the United States. Urban Juve’s skin care products are sold through e-commerce and through retail stores in Canada, with distribution agreements signed for the United States and Italy. Urban Juve has licensed its formulas to Yield Growth 100% owned subsidiary UJ Topicals Inc., which is launching its cannabis topicals line through a distribution network of 400 stores in Oregon, U.S.A.

For more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram. Visit www.urbanjuve.comand #findyourjuve across social platforms to learn, engage and shop.

Investor Relations Contacts:

Penny Green, President & CEO

Kristina Pillon, Investor Relations
invest@yieldgrowth.com
1-833-514-BOSS   1-833-514-2677
1-833-515-BOSS   1-833-515-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, and sale of, and demand for, Urban Juve and UJ Topicals products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/19706b1d-04f3-452d-a515-35c3b975801e

Click here to connect with Yield Growth Corp. (CSE:BOSS) for an Investor Presentation. 

Source: globenewswire.com

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less